Selected article for: "amino acid and hcmv infection"

Author: Melnik, Lilia I; Garry, Robert F; Morris, Cindy A
Title: Peptide inhibition of human cytomegalovirus infection
  • Document date: 2011_2_22
  • ID: 0p6x4lwx_22
    Snippet: Enfurvitide, a 36-amino acid peptide also known as Fuzeon works by inhibiting the structural rearrangement of HIV-1 gp41 to block the fusion of HIV-1 virions with their target cell membrane. Brennan-Benson et al. showed that Fuzeon prevents vertical transmission of HIV-1 in pregnancy, but does not cross the placenta [55] . We have shown that some peptides are effective at preventing HCMV infection. Those lead peptides will be studied further and .....
    Document: Enfurvitide, a 36-amino acid peptide also known as Fuzeon works by inhibiting the structural rearrangement of HIV-1 gp41 to block the fusion of HIV-1 virions with their target cell membrane. Brennan-Benson et al. showed that Fuzeon prevents vertical transmission of HIV-1 in pregnancy, but does not cross the placenta [55] . We have shown that some peptides are effective at preventing HCMV infection. Those lead peptides will be studied further and modified to increase their efficacy, solubility and delivery.

    Search related documents:
    Co phrase search for related documents
    • acid peptide and structural rearrangement: 1
    • acid peptide and target cell membrane: 1
    • cell membrane and hcmv infection: 1, 2, 3, 4, 5
    • cell membrane and hcmv infection prevent: 1
    • cell membrane and lead peptide: 1, 2
    • cell membrane and structural rearrangement: 1, 2, 3
    • cell membrane and target cell membrane: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cell membrane and target cell membrane virion fusion: 1, 2
    • cell membrane and vertical transmission: 1, 2, 3
    • cell membrane and virion fusion: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • hcmv infection and vertical transmission: 1
    • hcmv infection and virion fusion: 1, 2
    • lead peptide and target cell membrane: 1
    • lead peptide and target cell membrane virion fusion: 1
    • lead peptide and virion fusion: 1
    • target cell membrane and virion fusion: 1, 2
    • target cell membrane virion fusion and virion fusion: 1, 2